Phibro Animal Health (NASDAQ:PAHC) Downgraded by StockNews.com to “Buy”

StockNews.com lowered shares of Phibro Animal Health (NASDAQ:PAHCFree Report) from a strong-buy rating to a buy rating in a research report sent to investors on Thursday morning.

A number of other brokerages have also weighed in on PAHC. Morgan Stanley boosted their target price on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Barclays boosted their price objective on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a report on Tuesday, November 12th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $20.50.

Get Our Latest Stock Report on Phibro Animal Health

Phibro Animal Health Trading Up 9.9 %

NASDAQ:PAHC opened at $24.58 on Thursday. The stock has a market cap of $995.49 million, a price-to-earnings ratio of 57.16, a PEG ratio of 0.56 and a beta of 0.52. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The company’s 50 day moving average price is $21.87 and its 200-day moving average price is $21.60. Phibro Animal Health has a 52 week low of $10.03 and a 52 week high of $25.98.

Phibro Animal Health (NASDAQ:PAHCGet Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. On average, equities research analysts forecast that Phibro Animal Health will post 1.62 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.95%. Phibro Animal Health’s dividend payout ratio is currently 111.63%.

Hedge Funds Weigh In On Phibro Animal Health

Several institutional investors have recently made changes to their positions in the business. Geode Capital Management LLC increased its holdings in Phibro Animal Health by 5.7% during the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after buying an additional 27,201 shares during the last quarter. Barclays PLC increased its stake in shares of Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after purchasing an additional 29,271 shares in the last quarter. Algert Global LLC raised its holdings in Phibro Animal Health by 521.1% in the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock worth $1,606,000 after purchasing an additional 59,850 shares during the period. FMR LLC raised its holdings in Phibro Animal Health by 22.7% in the 3rd quarter. FMR LLC now owns 39,310 shares of the company’s stock worth $885,000 after purchasing an additional 7,270 shares during the period. Finally, BNP Paribas Financial Markets lifted its position in Phibro Animal Health by 3.1% during the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after purchasing an additional 729 shares in the last quarter. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Recommended Stories

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.